{"transactions":[{"id":306595,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-08-06T21:01:00.000Z","date":"2026-08-04","kind":"grant","planned":false,"acquired":true,"shares":13477,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated in connection with the Issuer's Long-Term Growth Program, as previously reported in the Issuer's Current Report on Form 8-K filed with the Securities and Exchange Commission on August 3, 2026. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One hundred percent of the RSUs vest on the 12-month anniversary of the grant date, which is August 4, 2026."}],"balance_after":32495,"source":{"system":"sec-edgar","filing":"0000313616-26-000183","document":"wk-form4_1786050057.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000183/wk-form4_1786050057.xml","form_type":"4"}},{"id":312340,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2026-03-04T00:52:06.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":17964,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"Fifty percent of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2026."}],"balance_after":17964,"derivative":{"exercise_price":210.64,"expiration_date":"2036-03-01","underlying":"Common Stock","underlying_shares":17964},"source":{"system":"sec-edgar","filing":"0000313616-26-000094","document":"wk-form4_1772585524.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000094/wk-form4_1772585524.xml","form_type":"4"}},{"id":312339,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-03-04T00:52:06.000Z","date":"2026-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":284,"price":210.64,"value":59821.76,"ownership":{"direct":true},"balance_after":19018,"source":{"system":"sec-edgar","filing":"0000313616-26-000094","document":"wk-form4_1772585524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000094/wk-form4_1772585524.xml","form_type":"4"}},{"id":312338,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-03-04T00:52:06.000Z","date":"2026-03-01","kind":"grant","planned":false,"acquired":true,"shares":6647,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. Twenty-five percent of the RSUs vest on each of the first four anniversaries of the grant date, which is March 1, 2026."}],"balance_after":19302,"source":{"system":"sec-edgar","filing":"0000313616-26-000094","document":"wk-form4_1772585524.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000094/wk-form4_1772585524.xml","form_type":"4"}},{"id":312770,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-02-25T22:01:45.000Z","date":"2026-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":344,"price":209.19,"value":71961.36,"ownership":{"direct":true},"balance_after":12655,"source":{"system":"sec-edgar","filing":"0000313616-26-000073","document":"wk-form4_1772056903.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000073/wk-form4_1772056903.xml","form_type":"4"}},{"id":314180,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-02-06T22:01:17.000Z","date":"2026-02-04","kind":"grant","planned":false,"acquired":true,"shares":1695,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 24, 2023, the Compensation Committee of the Company's Board of Directors awarded the reporting person performance stock units under the Danaher Corporation 2007 Omnibus Incentive Plan. This Form 4 is being filed in connection with the determination by the Compensation Committee that the performance criteria of the award have been achieved. The award remains subject to a holding period that continues through December 31, 2027."}],"balance_after":12999,"source":{"system":"sec-edgar","filing":"0000313616-26-000054","document":"wk-form4_1770415274.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000054/wk-form4_1770415274.xml","form_type":"4"}},{"id":314428,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2026-02-04T22:01:24.000Z","date":"2026-02-02","kind":"grant","planned":false,"acquired":true,"shares":275,"price":218.89,"value":60194.75,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F2","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F3","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":1447.296,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":275},"source":{"system":"sec-edgar","filing":"0000313616-26-000040","document":"wk-form4_1770242481.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000040/wk-form4_1770242481.xml","form_type":"4"}},{"id":314427,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2026-02-04T22:01:24.000Z","date":"2026-02-02","kind":"tax_withholding","planned":false,"acquired":false,"shares":852,"price":223.42,"value":190353.84,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This transaction relates to the withholding of certain shares for tax purposes in connection with the distribution of performance-based restricted stock units."}],"balance_after":11304,"source":{"system":"sec-edgar","filing":"0000313616-26-000040","document":"wk-form4_1770242481.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361626000040/wk-form4_1770242481.xml","form_type":"4"}},{"id":946720,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2026-01-07T01:00:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":19000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026."}],"balance_after":19000,"derivative":{"exercise_price":7.08,"expiration_date":"2036-01-02","underlying":"Ordinary Shares","underlying_shares":19000},"source":{"system":"sec-edgar","filing":"0001667657-26-000002","document":"form4-01062026_080104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000166765726000002/form4-01062026_080104.xml","form_type":"4"}},{"id":946719,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2026-01-07T01:00:14.000Z","date":"2026-01-02","kind":"grant","planned":false,"acquired":true,"shares":9500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted share unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2026, June 15, 2026, September 15, 2026 and December 15, 2026."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":32500,"source":{"system":"sec-edgar","filing":"0001667657-26-000002","document":"form4-01062026_080104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000166765726000002/form4-01062026_080104.xml","form_type":"4"}},{"id":324774,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2025-03-04T22:00:17.000Z","date":"2025-03-01","kind":"grant","planned":false,"acquired":true,"shares":24067,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"One half of the options granted become exercisable on each of the third and fourth  anniversaries of the grant date, which is March 1, 2025."}],"balance_after":24067,"derivative":{"exercise_price":207.76,"expiration_date":"2035-03-01","underlying":"Common Stock","underlying_shares":24067},"source":{"system":"sec-edgar","filing":"0000313616-25-000066","document":"wk-form4_1741125609.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361625000066/wk-form4_1741125609.xml","form_type":"4"}},{"id":324773,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-03-04T22:00:17.000Z","date":"2025-03-01","kind":"tax_withholding","planned":false,"acquired":false,"shares":216,"price":207.76,"value":44876.16,"ownership":{"direct":true},"balance_after":12156,"source":{"system":"sec-edgar","filing":"0000313616-25-000066","document":"wk-form4_1741125609.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361625000066/wk-form4_1741125609.xml","form_type":"4"}},{"id":325328,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2025-02-25T22:02:18.000Z","date":"2025-02-24","kind":"tax_withholding","planned":false,"acquired":false,"shares":586,"price":211.14,"value":123728.04,"ownership":{"direct":true},"balance_after":12372,"source":{"system":"sec-edgar","filing":"0000313616-25-000056","document":"wk-form4_1740520932.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361625000056/wk-form4_1740520932.xml","form_type":"4"}},{"id":326659,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2025-02-04T22:34:46.000Z","date":"2025-02-01","kind":"grant","planned":false,"acquired":true,"shares":241,"price":222.74,"value":53680.34,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":1172.296,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":241},"source":{"system":"sec-edgar","filing":"0000313616-25-000026","document":"wk-form4_1738708480.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361625000026/wk-form4_1738708480.xml","form_type":"4"}},{"id":1310705,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2025-01-07T00:30:07.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":12500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025."}],"balance_after":12500,"derivative":{"exercise_price":14,"expiration_date":"2035-01-02","underlying":"Ordinary Shares","underlying_shares":12500},"source":{"system":"sec-edgar","filing":"0001415889-25-000917","document":"form4-01062025_070104.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000141588925000917/form4-01062025_070104.xml","form_type":"4"}},{"id":1310704,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2025-01-07T00:30:07.000Z","date":"2025-01-02","kind":"grant","planned":false,"acquired":true,"shares":6250,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2025, June 15, 2025, September 15, 2025 and December 15, 2025."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":23000,"source":{"system":"sec-edgar","filing":"0001415889-25-000917","document":"form4-01062025_070104.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000141588925000917/form4-01062025_070104.xml","form_type":"4"}},{"id":338464,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T22:05:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":6979,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One fourth of the options granted become exercisable on each of the first four anniversaries of the grant date, which is March 1, 2024."}],"balance_after":6979,"derivative":{"exercise_price":255.87,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":6979},"source":{"system":"sec-edgar","filing":"0000313616-24-000100","document":"wk-form4_1709676316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000100/wk-form4_1709676316.xml","form_type":"4"}},{"id":338463,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2024-03-05T22:05:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":16285,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is March 1, 2024."}],"balance_after":16285,"derivative":{"exercise_price":255.87,"expiration_date":"2034-03-01","underlying":"Common Stock","underlying_shares":16285},"source":{"system":"sec-edgar","filing":"0000313616-24-000100","document":"wk-form4_1709676316.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000100/wk-form4_1709676316.xml","form_type":"4"}},{"id":338462,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-03-05T22:05:35.000Z","date":"2024-03-01","kind":"grant","planned":false,"acquired":true,"shares":2932,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One fourth of the RSUs vest on each of the first four anniversaries of the grant date, which is March 1, 2024."}],"balance_after":12958,"source":{"system":"sec-edgar","filing":"0000313616-24-000100","document":"wk-form4_1709676316.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000100/wk-form4_1709676316.xml","form_type":"4"}},{"id":339134,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-02-27T22:01:48.000Z","date":"2024-02-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":866,"price":253.84,"value":219825.44,"ownership":{"direct":true},"balance_after":10026,"source":{"system":"sec-edgar","filing":"0000313616-24-000078","document":"wk-form4_1709071295.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000078/wk-form4_1709071295.xml","form_type":"4"}},{"id":339406,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2024-02-23T22:03:01.000Z","date":"2024-02-21","kind":"grant","planned":false,"acquired":true,"shares":3155,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On February 24, 2021, the Compensation Committee of the Company's Board of Directors awarded the reporting person performance stock units under the Danaher Corporation 2007 Omnibus Incentive Plan. This Form 4 is being filed in connection with the determination by the Compensation Committee that the performance criteria of the award have been achieved. The award remains subject to a holding period that continues through December 31, 2025."}],"balance_after":10892,"source":{"system":"sec-edgar","filing":"0000313616-24-000067","document":"wk-form4_1708725757.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000067/wk-form4_1708725757.xml","form_type":"4"}},{"id":341443,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2024-02-02T22:01:22.000Z","date":"2024-02-01","kind":"grant","planned":false,"acquired":true,"shares":216,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock."}],"balance_after":931.296,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":216},"source":{"system":"sec-edgar","filing":"0000313616-24-000035","document":"wk-form4_1706911258.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361624000035/wk-form4_1706911258.xml","form_type":"4"}},{"id":1687829,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2024-01-04T23:33:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":12000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024."}],"balance_after":12000,"derivative":{"exercise_price":18.08,"expiration_date":"2034-01-02","underlying":"Ordinary Shares","underlying_shares":12000},"source":{"system":"sec-edgar","filing":"0001209191-24-000885","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919124000885/doc4.xml","form_type":"4"}},{"id":1687828,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2024-01-04T23:33:08.000Z","date":"2024-01-02","kind":"grant","planned":false,"acquired":true,"shares":6000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2024, June 15, 2024, September 15, 2024 and December 15, 2024."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":16750,"source":{"system":"sec-edgar","filing":"0001209191-24-000885","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919124000885/doc4.xml","form_type":"4"}},{"id":346314,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2023-08-22T21:00:37.000Z","date":"2023-08-21","kind":"sale","planned":false,"acquired":false,"shares":590,"price":250.54,"value":147818.6,"ownership":{"direct":true},"balance_after":6939,"source":{"system":"sec-edgar","filing":"0000313616-23-000246","document":"wk-form4_1692738028.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000246/wk-form4_1692738028.xml","form_type":"4"}},{"id":1858838,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2023-06-12T16:07:33.000Z","date":"2023-06-08","kind":"grant","planned":false,"acquired":true,"shares":20000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests on the earlier of June 8, 2024, and the day immediately prior to the date of the next annual meeting of the Issuer's stockholders occurring after the date of the grant."}],"balance_after":20000,"derivative":{"exercise_price":0.11,"expiration_date":"2033-06-08","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001694665-23-000088","document":"wk-form4_1686600439.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466523000088/wk-form4_1686600439.xml","form_type":"4"}},{"id":349603,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2023-05-02T21:01:50.000Z","date":"2023-05-01","kind":"sale","planned":false,"acquired":false,"shares":500,"price":242.1928,"value":121096.4,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $242.1818 to $242.210, inclusive. The reporting person undertakes to provide to Danaher Corporation, any securityholder of Danaher Corporation, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in the footnotes to this Form 4."}],"balance_after":7529,"source":{"system":"sec-edgar","filing":"0000313616-23-000167","document":"wf-form4_168306128928187.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000167/wf-form4_168306128928187.xml","form_type":"4"}},{"id":349697,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2023-05-01T21:03:46.000Z","date":"2023-04-28","kind":"grant","planned":false,"acquired":true,"shares":0.723,"price":236.91,"value":171.28593,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents notional dividend accruals on phantom shares in the Danaher stock fund under one or more of the plans that form part of Danaher's deferred compensation program. The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the fund, which is the price shown in Table II, Column 8 above.  Effective June 1, 2023, notional dividend accruals on phantom shares in the Danaher stock fund under Danaher's deferred compensation program will no longer be invested in additional notional shares of Danaher common stock and instead will be invested in a notional fixed income investment option."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":635.378,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":0.723},"source":{"system":"sec-edgar","filing":"0000313616-23-000154","document":"wf-form4_168297501220430.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000154/wf-form4_168297501220430.xml","form_type":"4"}},{"id":352393,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2023-02-28T22:03:27.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":10849,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"One fourth of the options granted become exercisable on each of the first four anniversaries of the grant date, which is February 24, 2023."}],"balance_after":10849,"derivative":{"exercise_price":249.12,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":10849},"source":{"system":"sec-edgar","filing":"0000313616-23-000118","document":"wf-form4_167762177631136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000118/wf-form4_167762177631136.xml","form_type":"4"}},{"id":352392,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock options (right to buy)","published_at":"2023-02-28T22:03:27.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":16274,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is February 24, 2023."}],"balance_after":16274,"derivative":{"exercise_price":249.12,"expiration_date":"2033-02-24","underlying":"Common Stock","underlying_shares":16274},"source":{"system":"sec-edgar","filing":"0000313616-23-000118","document":"wf-form4_167762177631136.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000118/wf-form4_167762177631136.xml","form_type":"4"}},{"id":352391,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:03:27.000Z","date":"2023-02-24","kind":"grant","acquired":true,"shares":4015,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One fourth of the RSUs vest on each of the first four anniversaries of the grant date, which is February 24, 2023."}],"balance_after":8029,"source":{"system":"sec-edgar","filing":"0000313616-23-000118","document":"wf-form4_167762177631136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000118/wf-form4_167762177631136.xml","form_type":"4"}},{"id":352390,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2023-02-28T22:03:27.000Z","date":"2023-02-24","kind":"tax_withholding","acquired":false,"shares":481,"price":249.12,"value":119826.72,"ownership":{"direct":true},"balance_after":4014,"source":{"system":"sec-edgar","filing":"0000313616-23-000118","document":"wf-form4_167762177631136.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000118/wf-form4_167762177631136.xml","form_type":"4"}},{"id":354266,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2023-02-02T22:13:03.000Z","date":"2022-04-29","kind":"grant","acquired":true,"shares":0.172,"price":251.13,"value":43.19436,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents notional dividend accruals on phantom shares in the Danaher stock fund under one or more of the plans that form part of Danaher's deferred compensation program. The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the fund, which is the price shown in Table II, Column 8 above. Beginning in the third quarter of 2022, the Danaher reporting persons began reporting these quarterly notional dividend accruals on a current basis, which is why this Form 5 only reports the accrual that occurred in the second quarter of 2022."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":173.492,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":0.172},"source":{"system":"sec-edgar","filing":"0000313616-23-000079","document":"wf-form5_167537596516428.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000079/wf-form5_167537596516428.xml","form_type":"5"}},{"id":354283,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2023-02-02T22:08:45.000Z","date":"2023-02-01","kind":"grant","acquired":true,"shares":461,"price":267.5,"value":123317.5,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one or more of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."}],"balance_after":634.655,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":461},"source":{"system":"sec-edgar","filing":"0000313616-23-000069","document":"wf-form4_167537571122801.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000069/wf-form4_167537571122801.xml","form_type":"4"}},{"id":354467,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2023-01-30T22:04:13.000Z","date":"2023-01-27","kind":"grant","acquired":true,"shares":0.163,"price":265.98,"value":43.35474,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents notional dividend accruals on phantom shares in the Danaher stock fund under one or more of the plans that form part of Danaher's deferred compensation program. The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the fund, which is the price shown in Table II, Column 8 above."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":173.655,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":0.163},"source":{"system":"sec-edgar","filing":"0000313616-23-000033","document":"wf-form4_167511622200747.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361623000033/wf-form4_167511622200747.xml","form_type":"4"}},{"id":2062702,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2023-01-06T02:07:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":11500,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023."}],"balance_after":11500,"derivative":{"exercise_price":29.6,"expiration_date":"2033-01-03","underlying":"Ordinary Shares","underlying_shares":11500},"source":{"system":"sec-edgar","filing":"0001209191-23-002180","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919123002180/doc4.xml","form_type":"4"}},{"id":2062701,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2023-01-06T02:07:37.000Z","date":"2023-01-03","kind":"grant","acquired":true,"shares":5750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award. The RSUs shall vest in four equal installments on March 15, 2023, June 15, 2023, September 15, 2023 and December 15, 2023."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":10750,"source":{"system":"sec-edgar","filing":"0001209191-23-002180","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919123002180/doc4.xml","form_type":"4"}},{"id":357139,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2022-10-31T21:04:26.000Z","date":"2022-10-28","kind":"grant","acquired":true,"shares":0.172,"price":251.8,"value":43.3096,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents notional dividend accruals on phantom shares in the Danaher stock fund under one or more of the plans that form part of Danaher's deferred compensation program. The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the fund, which is the price shown in Table II, Column 8 above."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":173.492,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":0.172},"source":{"system":"sec-edgar","filing":"0000313616-22-000254","document":"wf-form4_166725024923517.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361622000254/wf-form4_166725024923517.xml","form_type":"4"}},{"id":359297,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2022-08-02T21:05:36.000Z","date":"2022-07-29","kind":"grant","acquired":true,"shares":0.148,"price":291.47,"value":43.13756,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents notional dividend accruals on phantom shares in the Danaher stock fund under one or more of the plans that form part of Danaher's deferred compensation program. The number of phantom shares accrued as a result of such notional dividend accruals is based on the closing price of Danaher common stock as reported on the NYSE on the date such dividend accruals are credited to the fund, which is the price shown in Table II, Column 8 above."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."}],"balance_after":173.32,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":0.148},"source":{"system":"sec-edgar","filing":"0000313616-22-000202","document":"wf-form4_165947429925196.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361622000202/wf-form4_165947429925196.xml","form_type":"4"}},{"id":2304554,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2022-04-05T17:41:41.000Z","date":"2022-04-01","kind":"grant","acquired":true,"shares":40000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 substantially equal monthly installments following the grant date and has a term of 10 years."}],"balance_after":40000,"derivative":{"exercise_price":3.36,"expiration_date":"2032-04-01","underlying":"Common Stock","underlying_shares":40000},"source":{"system":"sec-edgar","filing":"0001694665-22-000063","document":"wf-form4_164919488578075.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466522000063/wf-form4_164919488578075.xml","form_type":"4"}},{"id":365040,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Employee stock option (right to buy)","published_at":"2022-02-28T22:09:22.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":12626,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One half of the options granted become exercisable on each of the third and fourth anniversaries of the grant date, which is February 24, 2022."}],"balance_after":12626,"derivative":{"exercise_price":271.56,"expiration_date":"2032-02-24","underlying":"Common Stock","underlying_shares":12626},"source":{"system":"sec-edgar","filing":"0000313616-22-000095","document":"wf-form4_164608612520257.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361622000095/wf-form4_164608612520257.xml","form_type":"4"}},{"id":365039,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2022-02-28T22:09:22.000Z","date":"2022-02-24","kind":"grant","acquired":true,"shares":2210,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One third of the RSUs vest on each of the first, second, and third anniversaries of the grant date, which is February 24, 2022."}],"balance_after":4495,"source":{"system":"sec-edgar","filing":"0000313616-22-000095","document":"wf-form4_164608612520257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361622000095/wf-form4_164608612520257.xml","form_type":"4"}},{"id":365038,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Common Stock","published_at":"2022-02-28T22:09:22.000Z","date":"2022-02-24","kind":"tax_withholding","acquired":false,"shares":260,"price":271.56,"value":70605.6,"ownership":{"direct":true},"balance_after":2285,"source":{"system":"sec-edgar","filing":"0000313616-22-000095","document":"wf-form4_164608612520257.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361622000095/wf-form4_164608612520257.xml","form_type":"4"}},{"id":366874,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Science Officer"}}],"security":"Danaher Deferred Compensation Programs - Danaher Stock Fund","published_at":"2022-02-02T22:02:27.000Z","date":"2022-02-01","kind":"grant","acquired":true,"shares":173,"price":285.79,"value":49441.67,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"The notional shares convert on a one-for-one basis."},{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The vesting terms and manner and form of distribution of amounts contributed or deferred under the program are based upon the provisions of the respective plan, which provisions are summarized in the latest Danaher Corporation annual meeting proxy statement on Schedule 14A as filed with the Securities and Exchange Commission."},{"field":"derivative.underlying_shares","element":"underlyingSecurityShares","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F1","text":"Represents the Company's annual contribution to the Danaher stock fund in the reporting person's account under one of the plans that form part of Danaher's deferred compensation program. The Company contributions are deemed to be invested in a number of unfunded, notional shares of Danaher common stock. The price shown in Table II, Column 8 is the closing price per share of Danaher common stock as reported on the NYSE on the date used to determine the number of notional shares to be credited to the participant's account."}],"balance_after":173,"derivative":{"exercise_price":0,"underlying":"Common Stock","underlying_shares":173},"source":{"system":"sec-edgar","filing":"0000313616-22-000051","document":"wf-form4_164383932950126.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361622000051/wf-form4_164383932950126.xml","form_type":"4"}},{"id":2443974,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2022-01-05T22:18:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"This option is fully vested and exercisable."}],"balance_after":10000,"derivative":{"exercise_price":60.87,"expiration_date":"2032-01-03","underlying":"Ordinary Shares","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001209191-22-001808","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919122001808/doc4.xml","form_type":"4"}},{"id":2443973,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Ordinary Shares","published_at":"2022-01-05T22:18:22.000Z","date":"2022-01-03","kind":"grant","acquired":true,"shares":5000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Represents a restricted stock unit (\"RSU\") award.  The RSUs are fully vested."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"Each RSU represents a contingent right to receive one ordinary share."}],"balance_after":5000,"source":{"system":"sec-edgar","filing":"0001209191-22-001808","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919122001808/doc4.xml","form_type":"4"}},{"id":2777611,"issuer":{"id":5993,"kind":"organization","name":"BICYCLE THERAPEUTICS PLC","symbol":"BCYC"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (right to buy)","published_at":"2021-03-19T20:56:14.000Z","date":"2021-03-17","kind":"grant","acquired":true,"shares":32000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying this option shall vest in 36 equal monthly installments at the end of each calendar month following the date of grant."}],"balance_after":32000,"derivative":{"exercise_price":27.9,"expiration_date":"2031-03-17","underlying":"Ordinary Shares","underlying_shares":32000},"source":{"system":"sec-edgar","filing":"0001209191-21-022111","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000120919121022111/doc4.xml","form_type":"4"}},{"id":379428,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Employee Stock Option (Right to Buy)","published_at":"2021-02-26T23:49:26.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":13190,"price":223,"value":2941370.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"One third of the options granted become exercisable on each of the third, fourth and fifth anniversaries of the grant date, which is February 24, 2021."}],"balance_after":13190,"derivative":{"exercise_price":223,"expiration_date":"2031-02-24","underlying":"Common Stock","underlying_shares":13190},"source":{"system":"sec-edgar","filing":"0000313616-21-000046","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361621000046/edgar.xml","form_type":"4"}},{"id":379427,"issuer":{"id":2871,"kind":"organization","name":"DANAHER CORP /DE/","symbol":"DHR"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"SVP, Chief Scientific Officer"}}],"security":"Common Stock","published_at":"2021-02-26T23:49:26.000Z","date":"2021-02-24","kind":"grant","acquired":true,"shares":2545,"price":223,"value":567535.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"On the date indicated, Danaher Corporation granted the reporting person restricted stock units (RSUs) in the amount indicated. Since the RSUs are payable solely in common stock, they are being reported in Table I of this Form 4. One third of the RSUs granted vest on each of the third, fourth and fifth anniversaries of the grant date, which is February 24, 2021."}],"balance_after":2545,"source":{"system":"sec-edgar","filing":"0000313616-21-000046","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/313616/000031361621000046/edgar.xml","form_type":"4"}},{"id":3018596,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T21:17:07.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020010063/edgar.xml","form_type":"4"}},{"id":3018595,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T21:17:07.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":25000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-010063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020010063/edgar.xml","form_type":"4"}},{"id":3018594,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T21:17:07.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":8855,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-20-010063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020010063/edgar.xml","form_type":"4"}},{"id":3018593,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T21:17:07.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":11207,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-20-010063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020010063/edgar.xml","form_type":"4"}},{"id":3018592,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-10-01T21:17:07.000Z","date":"2020-10-01","kind":"disposition_to_issuer","acquired":false,"shares":20000,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Reflects disposition of options to acquire shares of Issuer common stock (each, an \"Issuer Option\") in accordance with that certain Agreement and Plan of Merger, dated as of August 19, 2020, by and among Johnson & Johnson, Vigor Sub, Inc. and the Issuer, pursuant to which, effective immediately prior to the effective time of the merger contemplated thereby (the \"Effective Time\"), each Issuer Option held by the Reporting Person became vested in full and, as of the Effective Time, was cancelled and converted into the right to receive an amount in cash (without interest) equal to the product obtained by multiplying (x) the aggregate number of shares of Issuer common stock underlying such Issuer Option immediately prior to the Effective Time by (y) the amount, if any, by which $52.50 exceeds the per share exercise price of such Issuer Option."}],"balance_after":0,"derivative":{"exercise_price":8.59,"expiration_date":"2026-03-09","underlying":"Common Stock","underlying_shares":20000},"source":{"system":"sec-edgar","filing":"0001179110-20-010063","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020010063/edgar.xml","form_type":"4"}},{"id":3051123,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-08-20T22:19:58.000Z","date":"2020-08-19","kind":"exercise","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":20000,"derivative":{"exercise_price":8.59,"exercise_date":"2017-03-09","expiration_date":"2026-03-09","underlying":"Common Stock","underlying_shares":10000},"source":{"system":"sec-edgar","filing":"0001179110-20-009202","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020009202/edgar.xml","form_type":"4"}},{"id":3051122,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T22:19:58.000Z","date":"2020-08-19","kind":"sale","acquired":false,"shares":10000,"price":52.09,"value":520900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-009202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020009202/edgar.xml","form_type":"4"}},{"id":3051121,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-08-20T22:19:58.000Z","date":"2020-08-19","kind":"exercise","acquired":true,"shares":10000,"price":8.59,"value":85900.0,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."}],"balance_after":10000,"source":{"system":"sec-edgar","filing":"0001179110-20-009202","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020009202/edgar.xml","form_type":"4"}},{"id":3100919,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2020-06-24T21:46:10.000Z","date":"2020-06-23","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr.Gutierrez-Ramos' continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":38.09,"expiration_date":"2030-06-23","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-20-007755","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020007755/edgar.xml","form_type":"4"}},{"id":3304131,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-23T22:14:15.000Z","date":"2020-01-21","kind":"sale","acquired":false,"shares":4356,"price":29.09,"value":126716.04,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F3","text":"This transaction was executed in multiple trades at prices ranging from $28.81 to $30.08. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":0,"source":{"system":"sec-edgar","filing":"0001179110-20-000729","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020000729/edgar.xml","form_type":"4"}},{"id":3304130,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2020-01-23T22:14:15.000Z","date":"2020-01-21","kind":"sale","acquired":false,"shares":5734,"price":29.1,"value":166859.4,"ownership":{"direct":true},"footnotes":[{"field":"kind","element":"transactionCoding","label":"F1","text":"This transaction was effected pursuant to a Rule 10b5-1 trading plan."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"This transaction was executed in multiple trades at prices ranging from $28.78 to $29.845. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote."}],"balance_after":4356,"source":{"system":"sec-edgar","filing":"0001179110-20-000729","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911020000729/edgar.xml","form_type":"4"}},{"id":3481468,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Unit","published_at":"2019-06-21T20:15:12.000Z","date":"2019-06-20","kind":"exercise","acquired":false,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-19-008022","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911019008022/edgar.xml","form_type":"4"}},{"id":3481467,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-21T20:15:12.000Z","date":"2019-06-19","kind":"grant","acquired":true,"shares":25000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr.Gutierrez-Ramos' continued service to the Company."}],"balance_after":25000,"derivative":{"exercise_price":12.64,"expiration_date":"2029-06-19","underlying":"Common Stock","underlying_shares":25000},"source":{"system":"sec-edgar","filing":"0001179110-19-008022","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911019008022/edgar.xml","form_type":"4"}},{"id":3481466,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2019-06-21T20:15:12.000Z","date":"2019-06-20","kind":"exercise","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":10090,"source":{"system":"sec-edgar","filing":"0001179110-19-008022","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911019008022/edgar.xml","form_type":"4"}},{"id":3489709,"issuer":{"id":108468,"kind":"organization","name":"Evelo Biosciences, Inc.","symbol":"EVLO"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2019-06-14T16:27:10.000Z","date":"2019-06-12","kind":"grant","acquired":true,"shares":31380,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The option vests in 36 equal monthly installments following the award grant date."}],"balance_after":31380,"derivative":{"exercise_price":7.07,"expiration_date":"2029-06-12","underlying":"Common Stock","underlying_shares":31380},"source":{"system":"sec-edgar","filing":"0001694665-19-000055","document":"wf-form4_156054401621064.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1694665/000169466519000055/wf-form4_156054401621064.xml","form_type":"4"}},{"id":3885086,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-22T21:50:34.000Z","date":"2018-06-20","kind":"exercise","acquired":false,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F4","text":"Restricted Stock Units convert into common stock on a one-for-one basis."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F5","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F5","text":"Subject to certain criteria, 100% of the restricted stock units shall vest on the first anniversary of the grant date."}],"balance_after":0,"derivative":{"underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001179110-18-008965","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911018008965/edgar.xml","form_type":"4"}},{"id":3885085,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2018-06-22T21:50:34.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":4356,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gutierrez-Ramos' continued service to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 4,356 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gutierrez-Ramos' continued service to the Company."}],"balance_after":4356,"derivative":{"underlying":"Common Stock","underlying_shares":4356},"source":{"system":"sec-edgar","filing":"0001179110-18-008965","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911018008965/edgar.xml","form_type":"4"}},{"id":3885084,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2018-06-22T21:50:34.000Z","date":"2018-06-20","kind":"grant","acquired":true,"shares":8855,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gutierrez-Ramos' continued service to the Company."}],"balance_after":8855,"derivative":{"exercise_price":22.3,"expiration_date":"2028-06-20","underlying":"Common Stock","underlying_shares":8855},"source":{"system":"sec-edgar","filing":"0001179110-18-008965","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911018008965/edgar.xml","form_type":"4"}},{"id":3885083,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Common Stock","published_at":"2018-06-22T21:50:34.000Z","date":"2018-06-20","kind":"exercise","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"balance_after":5734,"source":{"system":"sec-edgar","filing":"0001179110-18-008965","document":"edgar.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911018008965/edgar.xml","form_type":"4"}},{"id":3992664,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Stock Option (right to buy)","published_at":"2018-03-16T10:05:35.000Z","date":"2018-03-14","kind":"grant","acquired":true,"shares":120540,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The options vest and become exercisable in substantially equal monthly installments beginning on April 14, 2018 and continuing until March 14, 2022, subject to the Reporting Person continuing to provide services to the Issuer through each such vesting date."}],"balance_after":120540,"derivative":{"exercise_price":9.95,"expiration_date":"2028-03-14","underlying":"Common Stock","underlying_shares":120540},"source":{"system":"sec-edgar","filing":"0000899243-18-007675","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000089924318007675/doc4.xml","form_type":"4"}},{"id":4062952,"issuer":{"id":7801,"kind":"organization","name":"SYNLOGIC, INC."},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"See Remarks"}}],"security":"Common Stock","published_at":"2018-02-13T21:32:59.000Z","date":"2017-10-02","kind":"gift","acquired":false,"shares":10000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"This Report relates to a gift of 10,000 shares of common stock made by the Reporting Person on October 2, 2017. The gifted shares were fully vested as of the date of the gift in accordance with the vesting schedule described in footnote 2."},{"field":"balance_after","element":"sharesOwnedFollowingTransaction","label":"F2","text":"Pursuant to the terms of a restricted stock agreement by and between the Issuer and the Reporting Person, one-fourth of the total number of shares originally granted pursuant to the restricted stock agreement vested on May 14, 2016, with the remainder vesting in equal monthly installments until May 14, 2019, provided that at the relevant vesting dates the Reporting Person continues service to the Issuer and has not been terminated as defined in, and as determined under, the Issuer's 2017 Stock Incentive Plan."}],"balance_after":352619,"source":{"system":"sec-edgar","filing":"0000899243-18-003687","document":"doc5.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000089924318003687/doc5.xml","form_type":"5"}},{"id":4274623,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Restricted Stock Units","published_at":"2017-06-22T20:04:22.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":5734,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit represents a contingent right to receive one share of MNTA common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gutierrez-Ramos' continued service to the Company."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"Represents 5,734 restricted stock units, awarded pursuant to the Company's 2013 Incentive Award Plan, 100% of the restricted stock units shall vest on the first anniversary of the grant date, subject to Dr. Gutierrez-Ramos' continued service to the Company."}],"balance_after":5734,"derivative":{"underlying":"Common Stock","underlying_shares":5734},"source":{"system":"sec-edgar","filing":"0001179110-17-009448","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911017009448/edgar.xml","form_type":"4"}},{"id":4274622,"issuer":{"id":146313,"kind":"organization","name":"MOMENTA PHARMACEUTICALS INC","symbol":"MNTA"},"owners":[{"id":14341,"kind":"person","name":"Gutierrez-Ramos Jose-Carlos","position":1,"cik":"0001667657","reported_name":"Gutierrez-Ramos Jose-Carlos","relationship":{"director":true,"officer":false,"ten_percent_owner":false,"other":false}}],"security":"Stock Option (Right to Buy)","published_at":"2017-06-22T20:04:22.000Z","date":"2017-06-20","kind":"grant","acquired":true,"shares":11207,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"Represents an option granted by the Company pursuant to the Company's 2013 Incentive Award Plan.  The stock option will vest and become exercisable on the first anniversary of the grant date, subject to Dr. Gutierrez-Ramos' continued service to the Company."}],"balance_after":11207,"derivative":{"exercise_price":17.2,"expiration_date":"2027-06-20","underlying":"Common Stock","underlying_shares":11207},"source":{"system":"sec-edgar","filing":"0001179110-17-009448","document":"edgar.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1667657/000117911017009448/edgar.xml","form_type":"4"}}]}